Healthcare provider profile · identity verified

Sarah Brukae Sears, MD

Internal Medicine · INDIANAPOLIS, IN · NPI 1952384604

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	927	254
Levothyroxine Sodium	Levothyroxine Sodium	501	121
Amlodipine Besylate	Amlodipine Besylate	496	140
Losartan Potassium	Losartan Potassium	471	125
Omeprazole	Omeprazole	312	87
Metoprolol Succinate	Metoprolol Succinate	311	83
Gabapentin	Gabapentin	292	89
Lisinopril	Lisinopril	270	77
Hydrochlorothiazide	Hydrochlorothiazide	245	67
Simvastatin	Simvastatin	197	53
Trazodone Hcl	Trazodone Hcl	193	51
Meloxicam	Meloxicam	183	53
Montelukast Sodium	Montelukast Sodium	178	45
Rosuvastatin Calcium	Rosuvastatin Calcium	165	45
Sertraline Hcl	Sertraline Hcl	165	43
Pravastatin Sodium	Pravastatin Sodium	155	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	152	39
Alendronate Sodium	Alendronate Sodium	148	38
Pantoprazole Sodium	Pantoprazole Sodium	138	41
Albuterol Sulfate Hfa	Albuterol Sulfate	133	67
Fluoxetine Hcl	Fluoxetine Hcl	129	34
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	128	44
Furosemide	Furosemide	126	44
Metoprolol Tartrate	Metoprolol Tartrate	124	27
Duloxetine Hcl	Duloxetine Hcl	114	31
Escitalopram Oxalate	Escitalopram Oxalate	114	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	24
Metformin Hcl	Metformin Hcl	106	34
Metformin Hcl Er	Metformin Hcl	96	31
Potassium Chloride	Potassium Chloride	96	28
Jardiance	Empagliflozin	89	16
Allopurinol	Allopurinol	88	24
Bupropion Xl	Bupropion Hcl	87	28
Ozempic	Semaglutide	85	17
Hydralazine Hcl	Hydralazine Hcl	84	18
Tamsulosin Hcl	Tamsulosin Hcl	74	21
Zolpidem Tartrate	Zolpidem Tartrate	74	19
Cephalexin	Cephalexin	72	44
Eliquis	Apixaban	72	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	16
Mounjaro	Tirzepatide	71	14
Olmesartan Medoxomil	Olmesartan Medoxomil	67	20
Tramadol Hcl	Tramadol Hcl	67	19
Carvedilol	Carvedilol	66	20
Prednisone	Prednisone	66	57
Citalopram Hbr	Citalopram Hydrobromide	64	16
Clopidogrel	Clopidogrel Bisulfate	58	16
Nystatin	Nystatin	57	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	16
Estradiol	Estradiol	53	21
Ezetimibe	Ezetimibe	53	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	53	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	17
Warfarin Sodium	Warfarin Sodium	51	11
Famotidine	Famotidine	49	14
Synthroid	Levothyroxine Sodium	48	14
Valsartan	Valsartan	48	12
Alprazolam	Alprazolam	47	22
Clonidine	Clonidine	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	19
Glipizide	Glipizide	43	14
Solifenacin Succinate	Solifenacin Succinate	43	13
Spironolactone	Spironolactone	41	14
Paroxetine Hcl	Paroxetine Hcl	40	11
Glimepiride	Glimepiride	39	11
Januvia	Sitagliptin Phosphate	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	34
Celecoxib	Celecoxib	36	12
Mirtazapine	Mirtazapine	36	suppressed
Trulicity	Dulaglutide	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Irbesartan	Irbesartan	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	12
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Raloxifene Hcl	Raloxifene Hcl	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Premarin	Estrogens, Conjugated	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Azithromycin	Azithromycin	20	18
Methylprednisolone	Methylprednisolone	20	17
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Atenolol	Atenolol	18	suppressed
Junel	Norethindrone Ac/Eth Estradiol	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Lorazepam	Lorazepam	17	suppressed
Ondansetron Odt	Ondansetron	17	14
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Topiramate	Topiramate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Linzess	Linaclotide	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error